President of Morden, Drs. Stephen Hoge planned to tell lawmakers on Tuesday that the company received a “positive response” from the Food and Drug Administration to increase the dose from 10 to 15 in each vial of vaccine.

“The FDA has given us positive feedback on our proposal, and we are following a plan that may allow up to 15 doses to be taken from each vial,” reads Ready testimony For the House Committee on Energy and Commerce. “This will allow us to produce and deliver more doses more quickly.”

Starting on 13 March, more than 1.3 million postage stamps will be paid in the US by mid-March.

In a prepared statement, Hoge said that the move would speed up production and reduce pressure for material in high demand.

Hoge said the company is on track to deliver 100 million doses for its two-dose vaccine by the end of March, with 300 million doses available by the end of July. Modern intends to double its monthly shipments in April, reaching more than 40 million doses each month.

The FDA and Modern did not immediately respond to Granthshala News’ requests for comment on Tuesday morning.

Click here for complete coronary coverage

President Joe Biden previously stated that the US is on track to deliver more than 600 million doses of the COVID-19 vaccine between Modern and Pfizer by the end of July. If Johnson & Johnson removes regulatory barriers to its vaccine candidate, the US could receive around 700 million doses by mid-year, more than enough doses to vaccinate the entire population.